Hyperpigmentation refers to areas of the skin that become darker than the surrounding skin. The hyperpigmentation which is associated with CVI is typically seen in the lower legs, and it is caused by chronic inflammation. This type of hyperpigmentation is an indicator of unhealthy tissue, which is seen in advanced venous disease.
The signs and symptoms of hyperpigmentation are similar to those of CVI. These include:
Hyperpigmentation associated with CVI is caused by chronic inflammation from fluid buildup in the legs.
The main risk factor for Hyperpigmentation is uncontrolled CVI, Lymphedema and/or Phlebolymphedema.
Treatments for hyperpigmentation mainly target the underlying conditions (CVI/lymphedema/phlebolymphedema) and include:
No, hyperpigmentation is not typically completely reversable, although some patients may notice some degree of improvement. The goal of treatment at this advanced stage of CVI is to improve the health of the tissue. Early intervention and consistent use of prescribed treatments can yield the best results.
Hyperpigmentation related to venous insufficiency often presents as darkened skin around the ankles and lower legs. It typically requires treating the underlying venous issue to alleviate symptoms and prevent further discoloration. If the underlying issues are not addressed, the hyperpigmentation will likely get worse.
At Southlake Vein Care, we offer comprehensive treatments for venous insufficiency and other vein conditions. Schedule a consultation today to determine if your symptoms are due to vein problems.
Call our office at 972-378-5347 or request a consultation online to learn more.
In most cases, health insurance and Medicare will cover treatment of vein procedures, assuming the patient meets the criteria for treatment. Out of pocket expense depends on many factors, such as deductible met and the specifics of the individual plan. Our staff will work with you to understand the benefits and coverage provided by your insurance as well as any requirements that will need to be met.